Chuck Shear

Chuck joined CiVi Biopharma in August 2017 as chief development officer and leads the clinical development programs at CiVi Biopharma. Chuck has more than 32 years of clinical drug development experience at Merck Research Laboratories, Consolidated Serum Laboratories (CSL), Ltd and Pfizer Global R&D, where he held positions of increasing responsibility in clinical, regulatory and therapeutic area strategy and operations. Chuck’s primary therapeutic focus has been in cardiovascular disease and dyslipidemia.